Related Experiment Videos

Characterization of a human teratocarcinoma cell assay for inhibitors of metabolic cooperation

Cancer Research
|March 1, 1986
PubMed

Insights

A new human cell assay using PA-1 cells was developed to study metabolic cooperation. This assay effectively identifies inhibitors of metabolic cooperation, similar to existing animal cell assays.

Area of Science:

  • Cell Biology
  • Toxicology
  • Biochemistry

Background:

  • A validated Chinese hamster V79 cell assay exists for metabolic cooperation inhibitors.
  • A human cell-based assay is needed to avoid extrapolation issues from animal to human cells.

Purpose of the Study:

  • To develop and validate a human cell-based assay for inhibitors of metabolic cooperation.
  • To assess the utility of the PA-1 human teratocarcinoma cell line in this assay.

Main Methods:

  • Utilized the PA-1 human cell line in a metabolic cooperation assay.
  • The assay involved metabolic isolation of hypoxanthine-guanine phosphoribosyltransferase (HGPRT)-deficient cells using 6-thioguanine.
  • Tested phorbol ester analogues, including 12-O-tetradecanoylphorbol-13-acetate, phorbol-12,13-didecanoate, mezerein, and 4-phorbol-12,13-didecanoate.

Main Results:

  • 12-O-tetradecanoylphorbol-13-acetate and phorbol-12,13-didecanoate strongly inhibited metabolic cooperation.
  • Mezerein showed moderate inhibition, while 4-phorbol-12,13-didecanoate was inactive.
  • Results aligned with previous findings in V79 cells.

Conclusions:

  • The PA-1 cell line is a promising candidate for a human cell-based assay for metabolic cooperation inhibitors.
  • This human cell assay can provide more relevant data for human health risk assessment.

Related Concept Videos